Tailoring the Release Rates of Fluconazole Using Solid Dispersions in Polymer Blends

REFERENCES

• Ayub A. C., Gomes A. D. M., Lima M. V. C., Vianna-Soares C. D., Ferreira L. A. M. Topical delivery of Fluconazole: In vitro skin penetration and permeation using emulsions as dosage forms. Drug D. Ind. Pharm. 2007; 33(3)233–245
   Google Scholar
• Bikiaris D., Papageorgiou G. Z., Stergiou A., Pavlidou E., Karavas E., Kanaze F., Georgarakis M. Physicochemical studies on solid dispersions of poorly-water soluble drugs. Evaluation of capabilities and limitations of thermal analysis. Thermochemica Acta 2005; 439: 58–67
   Web of Science ®Google Scholar
• Bikiaris D., Prinos J., Botev M., Betchev C., Panayiotou C. Miscibility behaviour of polymer blends prepared from components with similar glass transitions using dynamic mechanical thermal analysis and differential scanning calorimetry. J. Appl. Polym. Sci. 2004; 93: 726–735
   Web of Science ®Google Scholar
• Craig D. Q. M. A review of thermal methods used for the analysis of the crystal form, solution thermodynamics and glass transition behaviour of polyethylene glycols. Thermochi. Acta 1995; 248: 189–203
   Web of Science ®Google Scholar
• Craig D. Q. M. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int. J. Pharm. 2002; 231: 131–144
   PubMed Web of Science ®Google Scholar
• Edlund U., Albertsson A.-C. Microspheres from poly(D, L-lactide)/poly(1,5-dioxepan-2-one) miscible blends for controlled drug delivery. J. Bio. Comp. Polym. 2000; 15: 214–221
   Web of Science ®Google Scholar
• Fekete P., Virgula J., Furdyga E., Leventiszne H. M., Klebovich I., Baloghne N. K. Fluconazole capsules with improved release. WO Patent, 2005002553, 2005
   Google Scholar
• Ford J. L. The current status of solid dispersions. Pharm. Acta Helv. 1986; 61: 69–88
   PubMedGoogle Scholar
• Gu X. J., Jiang W. Characterization of polymorphic forms of Fluconazole using transform raman spectroscopy. J. Pharm. Sci. 1995; 84(12)1438–1441
   PubMed Web of Science ®Google Scholar
• Gupta P., Bansal A. K. Devitrification of amorphous celecoxib. AAPS Pharm. Sci. Tech. 2005; 6: E223–E230
   PubMed Web of Science ®Google Scholar
• Gupta P., Thilagavathi R., Chakraborti A. K., Bansal A. K. Role of molecular interactions in stability of celecoxib-PVP amorphous systems. Mol. Pharm. 2005; 2: 384–391
   PubMed Web of Science ®Google Scholar
• Hörter D., Dressman J. B. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv. Drug Deliv. Rev. 2001; 56: 75–87
   Google Scholar
• Hu J., Johnston K. P., Williams R. O., III. Nanoparticle engineering processes for enhancing the dissolution rates of poorly watersSoluble drugs. Drug Dev. Ind. Pharm. 2004; 30(3)233–245
   PubMed Web of Science ®Google Scholar
• Kanaze F. I., Kokkalu E., Niopas I., Georgarakis E., Stergiou A., Bikiaris D. Dissolution enhancement of flavonoids by solid dispersion in PVP and PEG matrices. A comparative study. J. Appl. Polym. Sci. 2006; 102: 460–471
   Web of Science ®Google Scholar
• Karavas E., Ktistis G., Xenakis A., Georgarakis E. Effect of hydrogen bonding interactions on the release mechanism of Felodipine from nanodispersions with poly(vinyl pyrrolidone). Eur J Pharm Biopharm. 2006a; 63: 103–114
   PubMed Web of Science ®Google Scholar
• Karavas E., Georgarakis E., Bikiaris D. Adjusting drug release by using miscible polymer blends as effective drug carriers. J. Therm. Anal. Cal. 2006b; 84: 125–133
   Web of Science ®Google Scholar
• Karavas E., Georgarakis E., Bikiaris D. Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics. Eur. J. Pharm. Bio. 2006c; 64: 115–126
   PubMed Web of Science ®Google Scholar
• Karavas E., Georgarakis E., Bikiaris D. Felodipine nanodispersions as active core for predictable pulsatile chronotherapeutics using PVP/HPMC blends as coating layer. Int. J. Pharm. 2006d; 313: 189–197
   PubMed Web of Science ®Google Scholar
• Karavas E., Georgarakis E., Bikiaris D., Thomas T., Katsos V., Xenakis A. Hydrophilic matrices as carries in felodipine solid dispersion systems. Progr. Coll. Polym. Sci. 2001; 118: 149–152
   Google Scholar
• Karavas E., Georgarakis E., Sigalas M. P., Avgoustakis K., Bikiaris D. In situ investigation of the release mechanism of a sparingly water-soluble drug from its solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions. Eur. J. Pharm. Bio. 2007; 340: 76–83
   Google Scholar
• Kaushal A. M., Gupta P., Bansal A. K. Amorphous drug delivery systems: Molecular aspects, design and performance. Crit. Rev. Ther. Drug Carrier Syst. 2004; 21: 133–193
   PubMedGoogle Scholar
• Koo C. G. L., Frantzich S., Rosinski A., Sjöström M., Hoogstraate J. Oral gingival delivery systems from chitosan blends with hydrophilic polymers. Eur. J. Pharm. Biopharm. 2003; 55: 47–56
   PubMed Web of Science ®Google Scholar
• Leuner C., Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 2000; 50: 47–60
   PubMed Web of Science ®Google Scholar
• Lyu S. P., Sparer R., Hobot S., Dang K. Adjusting drug diffusivity using miscible polymer blends. J. Controlled Release 2005; 102: 679–686
   PubMed Web of Science ®Google Scholar
• Matsumoto T., Zografi G. Physical properties of solid molecular dispersion of Indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to Indomethacin Crystallization. Pharm. Res 1999; 16: 1722–1728
   PubMed Web of Science ®Google Scholar
• Mitchell S. A., Reynolds T. D., Dasbach T. P. A compaction process to enhance dissolution of poorly water-soluble drugs using hydroxypropyl methylcellulose. Int. J. Pharm. 2003; 250: 3–11
   PubMed Web of Science ®Google Scholar
• Nyamweya N., Hoag S. W. Assessment of polymer-polymer interactions in blends of HPMC and film forming polymers by modulated temperature differential scanning calorimetry. Pharm. Res. 2000; 17: 625–631
   PubMed Web of Science ®Google Scholar
• Okimoto K., Miyake M., Ibuki R., Yasumura M., Ohnishi N., Nakai T. Dissolution mechanism and rate of solid disperion particles of nivaldipine with hydroxypropylmethylecellulose. Int. J. Pharm. 1997; 159: 85–93
   Web of Science ®Google Scholar
• Pandit N. K., Strykowski J. M., McNally E. J., Waldbillig A. M. Surfactant solutions as media for dissolution testing of a poorly water-soluble drug. Drud. Dev. Ind. Pharm. 1985; 32(5)559–567
   Google Scholar
• Papageorgiou G. Z., Bikiaris D. N. Miscibility study of poly(propylene succinate)/poly(ethylene succinate) and poly(ethylene succinate)/poly(butylene succinate) blends. J. Polym. Sci. Polym. Phys. 2006; 44: 584–597
   Web of Science ®Google Scholar
• Papageorgiou G. Z., Bikiaris D., Karavas E., Politis S., Docoslis A., Park Y., Stergiou A., Georgarakis E. Effect of physical state and particle size distribution on dissolution enhancement of Nimodipine/PEG solid dispersions prepared by melt mixing and solvent evaporation. The APPS Journal 2006; 8: E623–E631
   Google Scholar
• Porta V., Chang K. H., Storpirtis S. Evaluation of the bioequivalence of capsules containing 150 mg of fluconazole. Int. J. Pharm. 2005; 288: 81–86
   PubMed Web of Science ®Google Scholar
• Serajudin A. T. M. Solid dispersion of poorly water soluble drugs: Early promises, subsequent problems, and recent breakthroughs. J. Pharm. Sci. 1999; 88: 1058–1066
   PubMed Web of Science ®Google Scholar
• Tantishaiyakul V., Kaewnopparat N., Ingkatawornwon g. S. Properties of solid dispersions of piroxicam in polyvinylpyrrolidone. Int. J. Pharm. 1999; 181: 143–151
   PubMed Web of Science ®Google Scholar
• Tomkins A., Kontopoulou M., Amsden B. Preparation and characterization of blends of star-poly(ε-caprolactone-co-D, L-lactide) and oligo (ε-caprolactone). J. Biomater. Sci., Polym. Ed. 2005; 16: 1009–1017
   PubMed Web of Science ®Google Scholar
• Van den Mooter G., Wuyts M., Blaton N., Busson R., Grobet P., Augustijns P., Kinget R. Physical stabilization of amorphous ketoconazole in solid dispersion with polyvinylpyrrolidone K25. Eur. J. Pharm. Sci. 2001; 12: 261–269
   PubMed Web of Science ®Google Scholar
• Vaughn J., McConville J. T., Crisp M. T., Johnston K. P., Williams R. O., 3rd. Supersaturation produces high bioavailability of amorphous danazol particles formed by evaporative precipitation into aqueous solution and spray freezing into liquid technologies. Drug Dev. Ind. Phram. 2006; 32(5)559–567
   PubMed Web of Science ®Google Scholar
• Verheyen S., Blaton N., Kinget R., Van den Mooter G. Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions. Int J. Pharm. 2002; 249: 45–58
   PubMed Web of Science ®Google Scholar
• Wong S. M., Kellaway I. W., Murdan S. Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant containing microparticles. Int. J. Pharm. 2006; 317(1)61–68
   PubMedGoogle Scholar